ClinicalTrials.Veeva

Menu

Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing

University of Michigan logo

University of Michigan

Status

Completed

Conditions

Opioid Prescribing

Treatments

Behavioral: Push reports

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04776928
HUM00186352
5R01DA042859-04 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The objective of this project is to leverage the Michigan Surgical Quality Collaborative's (MSQC) existing network and surgeon performance feedback platform to improve opioid prescribing practices for surgeons within the network found to be prescribing in a manner discordant with published guidelines and to inform best practices for future surgical quality improvement initiatives.

The study is being completed to learn more about the effectiveness, feasibility, and acceptability and that the goal is both to evaluate how effective this intervention and mechanism are for changing surgeon opioid prescribing behavior and to inform best practices for future quality initiatives. The study hypothesizes that provider-level feedback will allow clinicians to tailor postoperative prescribing more closely to patient consumption, and reduce excess postoperative prescribing.

The cohort of surgeons which have been identified as outliers by the Michigan Surgical Quality Collaborative (MSQC) will be be invited to participate in this trial. The study team will send surgeons belonging to sites that signed the Exhibit B-1 form the provider-level push notifications (98 participants). In this study de-identified prescribing data will also be analyzed for sites that do not sign the Exhibit B-1 form (105 participants).

The study team will approach 98 surgeons receiving the provider-level push notifications in one wave.

Enrollment

217 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Surgeons already participating in and sharing data with the Michigan Surgical Quality Collaborative (MSQC) who perform procedures of interest
  • Surgeons within MSQC who have median prescribing > 1 pill equivalents over the published recommendation
  • Surgeons within MSQC who perform surgeries at a hospital that have agreed to participate in this research

Exclusion criteria

  • Surgeons not identified in the MSQC data as having a valid National Provider Identifier (NPI)

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

217 participants in 2 patient groups

Provider-level push report notifications
Experimental group
Description:
Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site.
Treatment:
Behavioral: Push reports
No intervention
No Intervention group
Description:
Sites who did not sign Exhibit B-1.

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems